CONMED Corporation
CNMD
$38.46
-$0.95-2.41%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.74M | 2.86M | 21.42M | 6.04M | 33.76M |
| Total Depreciation and Amortization | 17.65M | 18.61M | 18.57M | 18.25M | 16.61M |
| Total Amortization of Deferred Charges | 2.74M | 1.28M | 1.39M | 1.44M | 2.84M |
| Total Other Non-Cash Items | 25.23M | 9.61M | 5.15M | 15.17M | 14.02M |
| Change in Net Operating Assets | -16.02M | 21.33M | -17.40M | 636.00K | -23.88M |
| Cash from Operations | 46.34M | 53.69M | 29.13M | 41.53M | 43.34M |
| Capital Expenditure | -5.11M | -5.19M | -5.73M | -3.78M | -4.04M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.00M | 0.00 | 0.00 | 850.00K | -- |
| Cash from Investing | -7.11M | -5.19M | -5.73M | -2.93M | -4.04M |
| Total Debt Issued | 187.00M | 167.00M | 200.67M | 166.00M | 150.00M |
| Total Debt Repaid | -207.00M | -196.00M | -211.67M | -180.59M | -186.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.19M | -6.19M | -6.19M | -6.18M | -6.18M |
| Other Financing Activities | -11.18M | -8.34M | -9.34M | -7.63M | -8.89M |
| Cash from Financing | -37.37M | -43.53M | -26.53M | -28.40M | -51.07M |
| Foreign Exchange rate Adjustments | 34.00K | 20.00K | 1.57M | 819.00K | -2.24M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.89M | 4.99M | -1.55M | 11.03M | -14.01M |